Imagine a career in a field you can’t imagine. Dominique Constantini parlayed her commitment to immunology to meeting unmet ...

ALX Oncology Holdings Inc. (NASDAQ:ALXO), a biopharmaceutical company currently valued at $93.36 million, has announced the adoption of a new equity incentive plan, effective January 16, 2025. The ...

Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...

Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced plans to launch its validated ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional ...

For over a century, radiotherapy has revolutionised cancer treatment. Technological advancements aim to deliver high doses to ...

After selling its PI3Kα program to Eli Lilly, Scorpion will spinout out a different entity, which will be owned by the ...

At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling ...

Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment with a current market capitalization of $803 million, has been making ...

Elevation Oncology Inc (ELEV) stock saw a decline, ending the day at $0.73 which represents a decrease of $-0.05 or -6.41% from the prior close of $0.78. The stock opened at $0.78 and touched a low of ...

JP Morgan attendees were told of Jazz Pharmaceuticals' plans to expand indications for two oncology drugs: zanidatamab and ...